Elevance Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Elevance Health, Inc. on July 28, 2025. The report discloses a corporate governance event regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The material change reported is the election of a new independent director:
- Steven H. Collis was elected to the Board of Directors, effective August 1, 2025.
- His term expires at the Company's 2027 annual meeting of shareholders.
- Mr. Collis was appointed to the Audit and Finance Committees.
- The Board determined Mr. Collis qualifies as an "audit committee financial expert."
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on operations, or discussion of risks and contingencies. Regarding compensation, Mr. Collis will receive standard compensation for non-employee directors as detailed in the Company's Form 10-Q for the quarter ended June 30, 2025. No unusual items were reported.
Investor Verification Checklist
- Verify the effective date of Steven H. Collis's board service (August 1, 2025).
- Review the Company's Form 10-Q for the quarter ended June 30, 2025, to understand the standard compensation program for non-employee directors.
- Confirm Mr. Collis's qualifications as an audit committee financial expert via the Board's determination.